Skip to main content
SpringerLink
Log in

Beta-blockers Prevent Sudden Death: so Why Is Their Use Limited after Myocardial Infarction?

  • Chapter
Cardiac Arrhythmias 1997

  • 87 Accesses

Abstract

There is overwhelming evidence that in the post myocardial infarction (MI) setting β-blockers (BB) are of benefit (in terms of safety and efficacy): they reduce recurrent MI, sudden death (SD) mortality, total mortality especially in patients with depressed ventricular function [1–14].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. The Norwegian Multicentre Study Group (1981) Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 309: 801–807

    Google Scholar 

  2. Beta-blockers Heart Attack Trial Research Group (1982) A randomized trial of propranolol in patients with acute myocardial infarction. Mortality results. JAMA 247: 1707–1714

    Article  Google Scholar 

  3. Herlitz J, Wilhelmsen C, Holmberg S et al (1984) The Goteborg Metoprolol Trial in Acute Myocardial Infarction. Am J Cardiol 53 (suppl D): 1D–50D

    Google Scholar 

  4. The Miami Trial Research Group (1985) Metoprolol in Acute Myocardial Infarction (MIAMI). A randomized placebo-controlled international trial. Eur Heart J 6: 199–226

    Google Scholar 

  5. Yusuf S, Peto R, Lewis J et al (1985) Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Progr Cardiovasc Dis 27: 335–371

    Article  CAS  Google Scholar 

  6. The Beta-blockers Pooling Project Research Group (1988) The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in postinfarction patients. Eur Heart J 9: 8–16

    Article  Google Scholar 

  7. Boissel JP, Leizorovicz A, Picolet H et al (1990) Secondary prevention after high risk acute myocardial infarction with low dose acebutolol. Am J Cardiol 66: 251–260

    Article  PubMed  CAS  Google Scholar 

  8. Olson G (1992) Metoprolol induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 13: 28–32

    Google Scholar 

  9. Pitt B (1992) The role of ß-adrenergic blocking agents in preventing sudden cardiac death. Circulation 85 (suppl I): 1107–1115

    Google Scholar 

  10. Yusuf S, Lessem J, Jha P et al (1993) Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials. J Hypertens 11 (suppl 4): S61–S63

    CAS  Google Scholar 

  11. Held P (1993) Effects of betablockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects. Am J Cardiol 71 (9): 39C–44C

    Article  PubMed  CAS  Google Scholar 

  12. Viscoli CM, Horwitz RI, Singer BH (1993) Beta-blockers after myocardial infarction: influence of first year clinical course on long term effectiveness. Ann Intern Med 118: 99–105

    Article  PubMed  CAS  Google Scholar 

  13. Teo KK, Yusuf S, Furberg CD (1993) Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA 270: 1589–1595

    Article  PubMed  CAS  Google Scholar 

  14. Castaigne A, Carville AF, Chazouilleres AF et al (1995) Le traitement médical après l’infarctus du myocarde: ordonnance réflexe ou ordonnance réfléchie. Arch Mal Coeur 88 (III): 45–49

    PubMed  Google Scholar 

  15. Reiffel J, Estes NAM III, Waldo AL et al (1994) A consensus report on antiarrhythmic drug use. Clin Cardiol 17: 103–110

    Article  PubMed  CAS  Google Scholar 

  16. Ryan TJ, Anderson JL, Antman EM et al (1996) ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. Circulation 94: 2341–2350

    Article  PubMed  CAS  Google Scholar 

  17. Cairns JA, Connolly SJ (1995) The problem of asymptomatic ventricular arrhythmias among survivors of acute myocardial infarction: role of amiodarone. ACC Current J Review 4 (2): 32–34

    Article  Google Scholar 

  18. Kennedy HL, Brooks MM, Barker AH et al (1994) Beta-Blocker therapy in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol 74: 674–680

    Article  PubMed  CAS  Google Scholar 

  19. Kjekshus J, Gilpin E, Cali G et al (1990) Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J 10: 423–428

    Google Scholar 

  20. Forman DE, Gutierrez Bernal JL, Wey JY (1992) Management of acute myocardial infarction in the very elderly. Am J Med 93: 315–326

    Article  PubMed  CAS  Google Scholar 

  21. Yusuf S, Wittes J, Probstifield J (1990) Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q wave myocardial infarction and beta-blockers. Am J Cardiol 66: 220–222

    Article  PubMed  CAS  Google Scholar 

  22. Glamann DB, Lange RA, Hillis LD (1991) Beneficial effects of long term beta-blockade after acute myocardial infarction in patients without anterograde flow in the infarct artery. Am J Cardiol 68: 150–154

    Article  PubMed  CAS  Google Scholar 

  23. Singh BN (1996) New antiarrhythmic drugs for ventricular arrhythmias: do they work? In: Raviele A (ed) Cardiac arrhythmias 1995. Springer, Berlin Heidelberg New York, pp 31–38

    Google Scholar 

  24. Echt DS, Liebson PR, Mitchell LB et al (1991) Mortality and morbidity in patients receiving flecainide, encainide and placebo: the Cardiac Arrhytmia Suppression Trial. N Engl J Med 324: 781–788

    Article  PubMed  CAS  Google Scholar 

  25. Schwartz PJ (1996) What have we learned from the SWORD trial? Can potassium channel blockers reduce sudden cardiac death? In: Raviele A (ed) Cardiac arrhythmias 1995. Springer, Berlin Heidelberg New York, pp 39–42

    Google Scholar 

  26. Avanzini F, Latini R, Maggioni A et al (1995) Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Arch Intern Med 155: 1041–1045

    Article  PubMed  CAS  Google Scholar 

  27. Garg R, Yusuf S (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273: 1450–1456

    Article  PubMed  CAS  Google Scholar 

  28. Ferguson D (1966) Meeting highlights. Circulation 94: 3–6

    Google Scholar 

  29. Naccarella FF, Palmieri M, Barbato G et al (1997) Critical evaluation of controlled clinical trials of antiarrhythmic therapy in the prevention of sudden death. In: Santini M (ed) Progress in clinical pacing 1996. Futura Media Services, New York, pp 531–546

    Google Scholar 

  30. Maggioni A (1997) personal communication

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servizio di Elettrofisiologia ed Elettrostimolazione, Dipartimento Cardiologico “A. De Gasperis”, Ospedale Ca’ Granda, Milano-Niguarda, Italy

    M. Lunati, M. Gasparini, G. Magenta, G. Cattafi & G. Gadaleta

Authors
  1. M. Lunati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Magenta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Cattafi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Gadaleta
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Divisione di Cardiologia, Ospedale Umberto I, Via Circonvallazione 50, I-30174, Venezia Mestre, Italy

    Antonio Raviele MD

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Italia

About this chapter

Cite this chapter

Lunati, M., Gasparini, M., Magenta, G., Cattafi, G., Gadaleta, G. (1998). Beta-blockers Prevent Sudden Death: so Why Is Their Use Limited after Myocardial Infarction?. In: Raviele, A. (eds) Cardiac Arrhythmias 1997. Springer, Milano. https://doi.org/10.1007/978-88-470-2288-1_29

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2288-1_29

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2290-4

  • Online ISBN: 978-88-470-2288-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation